Description
Development of a clinical leukaemia vaccine using dendritic cells loaded with the Wilms’ tumour (WT1) gene product
Article: Development of a clinical leukaemia vaccine using dendritic cells loaded with the Wilms’ tumour (WT1) gene product
€2.42
